A U.S. laboratory has announced the first human application of bacteriophages designed with artificial intelligence to combat antibiotic-resistant bacteria. According to Radical Numerics, the viruses were engineered using the Omnii-1 AI model and successfully eliminated antibiotic-resistant bacteria isolated from the patient's infection during laboratory testing.
The laboratory has not disclosed specific details about the type of infection or treatment results to protect patient privacy. This milestone represents a significant step in addressing the growing challenge of antibiotic resistance, a pressing public health concern where traditional antibiotics lose effectiveness against certain bacterial strains. Using AI to design targeted bacteriophages—viruses that naturally attack bacteria—offers a promising alternative approach to treating these resistant infections.